The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Flynn Daniel Lee since 2019.
This trader's CIK number is 1713712.
At the time of last reporting, Flynn Daniel Lee was the Chief Scientific Officer of Deciphera Pharmaceuticals, Inc.. (stock ticker symbol DCPH).
Also see all insider trading activities at Deciphera Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | DCPH | 0 | $0 | 3,025 | $44,520 | 0 | $0 |
| 2022 | DCPH | 0 | $0 | 3,134 | $31,368 | 0 | $0 |
| 2021 | DCPH | 0 | $0 | 508 | $24,825 | 0 | $0 |
| 2020 | DCPH | 0 | $0 | 0 | $0 | 205,935 | $599,970 |
| 2019 | DCPH | 0 | $0 | 667,739 | $28,930,175 | 636,210 | $1,252,903 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-06-16 | DCPH | Sale | 1,655 | 14.40 | 23,835 |
| 2023-02-16 | DCPH | Sale | 1,370 | 15.10 | 20,685 |
| 2022-06-16 | DCPH | Sale | 1,768 | 10.75 | 19,006 |
| 2022-02-16 | DCPH | Sale | 1,366 | 9.05 | 12,362 |
| 2021-02-16 | DCPH | Sale | 508 | 48.87 | 24,825 |
| 2020-08-10 | DCPH | Option Ex | 9,029 | 1.89 | 17,064 |
| 2020-07-22 | DCPH | Option Ex | 130,000 | 1.89 | 245,700 |
| 2020-01-16 | DCPH | Option Ex | 66,906 | 5.04 | 337,206 |
| 2019-12-12 | DCPH | Sale | 31,029 | 60.00 | 1,861,740 |
| 2019-12-09 | DCPH | Sale | 30,175 | 55.00 | 1,659,625 |
| 2019-12-10 | DCPH | Sale | 122,752 | 55.00 | 6,751,360 |
| 2019-12-09 | DCPH | Option Ex | 30,175 | 1.89 | 57,030 |
| 2019-12-10 | DCPH | Option Ex | 122,752 | 1.89 | 232,001 |
| 2019-11-08 | DCPH | Option Ex | 9,742 | 1.89 | 18,412 |
| 2019-11-08 | DCPH | Sale | 9,742 | 48.00 | 467,616 |
| 2019-11-11 | DCPH | Option Ex | 143,185 | 1.89 | 270,619 |
| 2019-11-11 | DCPH | Sale | 143,185 | 48.01 | 6,874,884 |
| 2019-10-28 | DCPH | Sale | 29,820 | 40.00 | 1,192,800 |
| 2019-10-28 | DCPH | Option Ex | 29,820 | 1.89 | 56,359 |
| 2019-08-13 | DCPH | Sale | 148,107 | 41.50 | 6,145,996 |
| 2019-08-13 | DCPH | Option Ex | 123,107 | 1.89 | 232,672 |
| 2019-02-21 | DCPH | Option Ex | 24,500 | 3.95 | 96,775 |
| 2019-01-16 | DCPH | Option Ex | 152,629 | 1.89 | 288,468 |
| 2019-01-16 | DCPH | Sale | 152,629 | 26.00 | 3,968,354 |
| 2019-01-11 | DCPH | Option Ex | 300 | 1.89 | 567 |
| 2019-01-11 | DCPH | Sale | 300 | 26.00 | 7,800 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Flynn Daniel Lee (Chief Scientific Officer of Deciphera Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.